GDC-0326
UNII MPJ2JD8YZX

Substance Identification & Data

This profile provides standardized clinical and technical data for Gdc-0326, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MPJ2JD8YZX.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1282514-88-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
MPJ2JD8YZX
CAS Registry Number
1282514-88-8
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
GDC-0326
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C19H22N6O3
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
SIKYDKLGPWRPMZ-LBPRGKRZSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
O1CCn2c(nc(c2)-c3n(ncn3)C(C)C)-c4c1cc(O[C@@H](C)C(=O)N)cc4

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Gdc-0326. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

PROPANAMIDE, 2-((5,6-DIHYDRO-2-(1-(1-METHYLETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)OXY)-, (2S)-

Technical Codes

GDC-0326